BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32622525)

  • 1. Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis.
    Usui T; Morito N; Shawki HH; Sato Y; Tsukaguchi H; Hamada M; Jeon H; Yadav MK; Kuno A; Tsunakawa Y; Okada R; Ojima T; Kanai M; Asano K; Imamura Y; Koshida R; Yoh K; Usui J; Yokoi H; Kasahara M; Yoshimura A; Muratani M; Kudo T; Oishi H; Yamagata K; Takahashi S
    Kidney Int; 2020 Aug; 98(2):391-403. PubMed ID: 32622525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutation in transcription factor MAFB causes Focal Segmental Glomerulosclerosis with Duane Retraction Syndrome.
    Sato Y; Tsukaguchi H; Morita H; Higasa K; Tran MTN; Hamada M; Usui T; Morito N; Horita S; Hayashi T; Takagi J; Yamaguchi I; Nguyen HT; Harada M; Inui K; Maruta Y; Inoue Y; Koiwa F; Sato H; Matsuda F; Ayabe S; Mizuno S; Sugiyama F; Takahashi S; Yoshimura A
    Kidney Int; 2018 Aug; 94(2):396-407. PubMed ID: 29779709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of the podocyte-expressed transcription factor Tcf21/Pod1 results in podocyte differentiation defects and FSGS.
    Maezawa Y; Onay T; Scott RP; Keir LS; Dimke H; Li C; Eremina V; Maezawa Y; Jeansson M; Shan J; Binnie M; Lewin M; Ghosh A; Miner JH; Vainio SJ; Quaggin SE
    J Am Soc Nephrol; 2014 Nov; 25(11):2459-70. PubMed ID: 24904088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of fibroblast specific protein 1 expression in the progression of adriamycin-induced glomerulosclerosis.
    Nakatani K; Asai O; Konishi N; Iwano M
    Biochem Biophys Res Commun; 2021 Aug; 567():148-153. PubMed ID: 34153685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte-specific Transcription Factors: Could MafB Become a Therapeutic Target for Kidney Disease?
    Morito N; Usui T; Ishibashi S; Yamagata K
    Intern Med; 2023 Jan; 62(1):11-19. PubMed ID: 35249929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Anti-Nephrin Antibody Mediated Podocyte Injury Model Using a C57BL/6 Mouse Strain.
    Takeuchi K; Naito S; Kawashima N; Ishigaki N; Sano T; Kamata K; Takeuchi Y
    Nephron; 2018; 138(1):71-87. PubMed ID: 28965116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic basis of adult-onset nephrotic syndrome and focal segmental glomerulosclerosis.
    Liu J; Wang W
    Front Med; 2017 Sep; 11(3):333-339. PubMed ID: 28776307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
    Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
    Daehn I; Casalena G; Zhang T; Shi S; Fenninger F; Barasch N; Yu L; D'Agati V; Schlondorff D; Kriz W; Haraldsson B; Bottinger EP
    J Clin Invest; 2014 Apr; 124(4):1608-21. PubMed ID: 24590287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
    Kim JS; Han BG; Choi SO; Cha SK
    Biomed Res Int; 2016; 2016():1630365. PubMed ID: 27088082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine A Treatment of Proteinuria in a New Case of MAFB-Associated Glomerulopathy without Extrarenal Involvement: A Case Report.
    Kaimori JY; Mori T; Namba-Hamano T; Morimoto T; Takuwa A; Motooka D; Okazaki A; Kobayashi K; Asahina Y; Kajimoto S; Doi Y; Oka T; Sakaguchi Y; Nakaya A; Isaka Y
    Nephron; 2021; 145(4):445-450. PubMed ID: 33975323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosis.
    Sakamoto K; Ueno T; Kobayashi N; Hara S; Takashima Y; Pastan I; Matsusaka T; Nagata M
    Am J Physiol Renal Physiol; 2014 Jan; 306(1):F98-F104. PubMed ID: 24154691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bigenic heterozygosity and the development of steroid-resistant focal segmental glomerulosclerosis.
    Löwik M; Levtchenko E; Westra D; Groenen P; Steenbergen E; Weening J; Lilien M; Monnens L; van den Heuvel L
    Nephrol Dial Transplant; 2008 Oct; 23(10):3146-51. PubMed ID: 18443213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
    Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
    Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS.
    Niculovic KM; Blume L; Wedekind H; Kats E; Albers I; Groos S; Abeln M; Schmitz J; Beuke E; Bräsen JH; Melk A; Schiffer M; Weinhold B; Münster-Kühnel AK
    J Am Soc Nephrol; 2019 Jun; 30(6):1021-1035. PubMed ID: 31040189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalin alleviates adriamycin-induced focal segmental glomerulosclerosis and proteinuria by inhibiting the Notch1-Snail axis mediated podocyte EMT.
    Dou Y; Shang Y; Shen Y; Qu J; Liu C; Cao J
    Life Sci; 2020 Sep; 257():118010. PubMed ID: 32598932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Mutation of Coenzyme Q
    Song CC; Hong Q; Geng XD; Wang X; Wang SQ; Cui SY; Guo MD; Li O; Cai GY; Chen XM; Wu D
    Chin Med J (Engl); 2018 Nov; 131(22):2666-2675. PubMed ID: 30425193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology.
    Akchurin O; Reidy KJ
    Pediatr Nephrol; 2015 Feb; 30(2):221-33. PubMed ID: 24584664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Mafb in podocytes protects against diabetic nephropathy.
    Morito N; Yoh K; Ojima M; Okamura M; Nakamura M; Hamada M; Shimohata H; Moriguchi T; Yamagata K; Takahashi S
    J Am Soc Nephrol; 2014 Nov; 25(11):2546-57. PubMed ID: 24722438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.